Ranolazine Safely Decreases Ventricular and Atrial Fibrillation in Timothy Syndrome (LQT8)

Long QT eight (LQT8), otherwise known as Timothy syndrome (TS), is a genetic disorder causing hyper‐activation of the L‐type calcium channel Cav 1.2. This calcium load and the resultant increase in the QT interval provide the substrate for ventricular arrhythmias. We previously presented a case in a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pacing and clinical electrophysiology 2012-03, Vol.35 (3), p.e62-e64
Hauptverfasser:	SHAH, DIPAK P., BAEZ‐ESCUDERO, JOSE L., WEISBERG, IAN L., BESHAI, JOHN F., BURKE, MARTIN C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetanilides - therapeutic use Adult Anti-Arrhythmia Agents - therapeutic use Atrial Fibrillation - drug therapy Autistic Disorder Drug Therapy, Combination electrophysiology—clinical Humans long QT Long QT Syndrome - drug therapy Male pharmacology Piperazines - therapeutic use Ranolazine Syndactyly - drug therapy Treatment Outcome Ventricular Fibrillation - drug therapy Verapamil - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!